|
Wingspan Stent to Remain on Market, But With Stricter Indications for Use
The FDA Wednesday said it is limiting use of Stryker’s Wingspan brain stent, but stopped short of removing the device from the market entirely — as consumer advocates had urged.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives